Charles Robb
2019
In 2019, Charles Robb earned a total compensation of $2.6M as Chief Financial Officer and Secretary at Corcept Therapeutics, a 8% decrease compared to previous year.
Compensation breakdown
Bonus | $308,881 |
---|---|
Option Awards | $1,845,345 |
Salary | $456,133 |
Total | $2,610,359 |
Robb received $1.8M in option awards, accounting for 71% of the total pay in 2019.
Robb also received $308.9K in bonus and $456.1K in salary.
Rankings
In 2019, Charles Robb's compensation ranked 4,671st out of 13,971 executives tracked by ExecPay. In other words, Robb earned more than 66.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,671 | 67th |
Manufacturing | 1,746 | 69th |
Chemicals And Allied Products | 610 | 72nd |
Drugs | 514 | 73rd |
Pharmaceutical Preparations | 387 | 72nd |
Robb's colleagues
We found three more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2019.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019